Skip to main content
. Author manuscript; available in PMC: 2020 Jan 15.
Published in final edited form as: Clin Cancer Res. 2019 Apr 16;25(14):4231–4237. doi: 10.1158/1078-0432.CCR-18-3886

Figure 1B. Overall survival of CR/CRi patients who underwent AHSCT.

Figure 1B

The solid line is the Kaplan-Meier estimated overall survival curve. The shaded area is the 95% confidence band.

Kaplan-Meier estimated overall survival (OS) of patients who achieved CR/CRi and proceeded to transplant. Solid line is the KM estimated OS curve, shaded area is the 95% confidence band. Five patients died out of a total of 11 patients. Median OS was 38.3 months (95% CI: 5.0-NA months). One-year OS rate was 63.6% (95% CI: 40.7–99.5%)

Median F/U time of the 6 patients alive was 26.5 months (range: 20.0–44.9 months).